Newer glucose-lowering agents versus thiazolidinediones on risk of incident cirrhosis and clinical decompensation events in patients with diabetes (Second-line GLDs and liver complications)

Documents

Study protocol

Initial protocol

Study protocol_cirrhosis_decompensation_9-25_submitted

Study results

Study results

Yang et al, Newer second-line GLDs vs. TZDs on cirrhosis risk among older US adult patients with T2D, J Diab Complic 2020

Study report

Other information

Publications

Study publications

Yang JY, Moon AM, Kim H, Pate V, Barritt AS IV, Crowley MJ, Buse JB, Stürmer T,…